Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives

BACKGROUND: Median survival of metastatic malignant melanoma is 6.0 to 7.5 months, with a 5-year survival of ~6.0%. Although long-term complete remissions are rare, few reports describe cases after chemotherapy. Fifty-three patients with metastatic melanoma were treated with Cystemustine, a chloroet...

Descripción completa

Detalles Bibliográficos
Autores principales: Durando, Xavier, Thivat, Emilie, D'Incan, Michel, Sinsard, Anne, Madelmont, Jean-Claude, Chollet, Philippe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310625/
https://www.ncbi.nlm.nih.gov/pubmed/16287507
http://dx.doi.org/10.1186/1471-2407-5-147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310625/
https://www.ncbi.nlm.nih.gov/pubmed/16287507
http://dx.doi.org/10.1186/1471-2407-5-147

Ejemplares similares